Understanding how brain cells maintain and form new connections throughout life has profound implications for treating neurodegenerative diseases and age-related cognitive decline. The discovery that cellular machinery originally designed for chromosome separation plays an unexpected role in neural plasticity opens new therapeutic avenues for conditions ranging from Alzheimer's to depression. This finding challenges the conventional view that kinetochore proteins function exclusively during cell division, revealing their critical importance in mature brain cells that no longer divide. The research demonstrates that kinetochore complex proteins actively regulate microtubule dynamics within postmitotic neurons, directly controlling the formation and maintenance of dendritic spines—the tiny protrusions where most excitatory synapses form. These spines are essential for learning, memory formation, and overall cognitive function. When kinetochore protein activity is disrupted, neurons lose their ability to properly form and stabilize these connection points. This mechanism represents a fundamental cellular process that bridges chromosome biology and neuroscience in ways previously unrecognized. The implications extend far beyond basic neurobiology. Since dendritic spine dysfunction underlies numerous neurological and psychiatric disorders, including autism spectrum disorders, schizophrenia, and various dementias, targeting kinetochore protein pathways could offer novel therapeutic strategies. This research suggests that drugs originally developed for cancer treatment, which often target kinetochore function, might be repurposed for neurological applications. However, the translation from laboratory findings to clinical applications remains complex, requiring careful consideration of how manipulating these proteins might affect both beneficial spine formation and potentially harmful cellular processes. The work represents early-stage basic research that will require extensive validation in disease models.